Literature DB >> 443977

Acute hepatitis with bridging necrosis due to hydralazine intake. Report of a case.

E Bartoli, G Massarelli, A Solinas, R Faedda, L Chiandussi.   

Abstract

A 59-year-old woman was admitted to the hospital for evaluation of her hypertension. She was treated with hydralazine; two days later a severe acute hepatitis supervened. On discontinuation of the agent, the liver damage disappeared, relapsed during inadvertent rechallenge, and healed following permanent withdrawal from the drug. Histologic study of the liver showed severe acute hepatitis with bridging necrosis (so-called subacute hepatitis). Six months after discontinuation of hydralazine, a second liver biopsy specimen showed a complete remission of the disease. This hydralazine-induced hepatitis appears to be fully reversible and to differ both on clinical and histological grounds from two previous reports documenting a granulomatous liver disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 443977

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  2 in total

1.  Hydrallazine-induced hepatitis?

Authors:  D B Barnett; S A Hudson; P W Golightly
Journal:  Br Med J       Date:  1980-05-10

Review 2.  Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig; R Axelsen
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.